Objectives Rheumatoid arthritis (RA) is a chronic, autoimmune inflammatory disease of
multiple joints that puts the patient at high risk for developing cardiovascular diseases …

Rheumatoid arthritis (RA) is an autoimmune disease accompanied by metabolic alterations.
The metabolic profiles of patients with RA can be determined using targeted and non …

Objective To evaluate the efficacy and safety of the oral Janus kinase (JAK) inhibitor
peficitinib versus placebo in Japanese patients with rheumatoid arthritis (RA). Methods In …

Objective To assess the efficacy and safety of subcutaneous administration of 30 mg or 80
mg of ozoralizumab plus methotrexate (MTX) in patients with rheumatoid arthritis (RA) …

ABSTRACT Introduction Ozoralizumab (Nanozora), a novel TNF inhibitor, was first approved
in Japan in September 2022 as a next-generation antibody for the treatment of rheumatoid …

Background The medicinal uses of plants are in many cases based exclusively on traditional
knowledge without enough scientific evidences. Different parts of Moringa oleifera were …

Rheumatoid arthritis (RA) is one of the most prevalent life-long autoimmune diseases with
an unknown genesis. It primarily causes chronic inflammation, pain, and synovial joint …

Objective To assess the efficacy and safety through a 52-week treatment with subcutaneous
ozoralizumab at 30 or 80 mg in patients with active rheumatoid arthritis despite methotrexate …

Background Shared decision-making (SDM), a process whereby physicians and patients
collaborate to select interventions, is not well understood for biologic treatment of …

Objectives The aim is to assess the efficacy and safety of a 52-week subcutaneous
ozoralizumab treatment at 30 and 80 mg without methotrexate (MTX) in active rheumatoid …